LONDON, UK. July 16th 2025 – UK-based digital diagnostics platform Bloodtest.co.uk has secured a £3 million investment from an American private equity group, in exchange for a 20% equity stake, valuing the company at £15 million. The investment reflects a growing appetite among international investors for scalable, technology-led healthcare solutions that put patients first.
Founded in 2023 by entrepreneur Giles Meadows, Bloodtest.co.uk began as a bedroom startup and is now on course to become one of the UK’s fastest-growing platforms for private blood testing and AI-powered aftercare. The platform is designed to give individuals fast, direct access to blood tests — with results and personalised insights delivered securely online, bypassing long wait times and unnecessary appointments in traditional healthcare settings.
The company is gaining strong early traction, with demand driven by people who value speed, discretion, and control over their own health. As healthcare systems face increasing pressure, the appetite for private diagnostics is growing — and Bloodtest.co.uk is well-positioned to lead that shift.
“This is a huge moment for us,” said Giles Meadows, Founder of Bloodtest.co.uk. “It’s been many months in the making to secure this investment, and it’s encouraging to work with people who understand where we want to position the company. Their belief in our mission and approach means a lot — this is just the beginning.”
A spokesperson for the American investment group added:
“We’re seeing sustained growth in demand for private healthcare services, particularly in markets like the UK, where innovation is reshaping access and delivery. What impressed us about Bloodtest.co.uk was not only its market traction but also the strength of its technical vision — especially the integration of AI-powered aftercare. This is a company solving real-world problems in a modern, scalable way, and we’re excited to support the next phase of its growth.”
The £3 million investment will be used to:
- Enhance the Bloodtest.co.uk digital platform
- Expand its diagnostics offering
- Accelerate user acquisition through targeted marketing
- Build commercial partnerships with healthcare providers, insurers, and employers
As demand for convenient, data-led healthcare increases, Bloodtest.co.uk is aiming to reshape how diagnostic testing is delivered — making it faster, more personal, and more intelligent.
ENDS